Butabarbital decreases consequences of sufentanil SL by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Intently. Coadministration of CYP3A4 inducers may perhaps minimize sufentanil concentrations and efficacy, possibly precipitating withdrawal syndrome in sufferers who may have made Bodily dependence to sufentanil. Discontinuation of concomitantly made... https://conanv518eas3.therainblog.com/profile